Literature DB >> 34484925

Loss of Neurologic Reserve in Progressive Multiple Sclerosis: A Paradigm Shift?

Joep Killestein1, Maria Liguori1.   

Abstract

Entities:  

Year:  2021        PMID: 34484925      PMCID: PMC8382419          DOI: 10.1212/CPJ.0000000000001106

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  9 in total

Review 1.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

2.  Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.

Authors:  Anna He; Bernd Merkel; James William L Brown; Lana Zhovits Ryerson; Ilya Kister; Charles B Malpas; Sifat Sharmin; Dana Horakova; Eva Kubala Havrdova; Tim Spelman; Guillermo Izquierdo; Sara Eichau; Maria Trojano; Alessandra Lugaresi; Raymond Hupperts; Patrizia Sola; Diana Ferraro; Jan Lycke; Francois Grand'Maison; Alexandre Prat; Marc Girard; Pierre Duquette; Catherine Larochelle; Anders Svenningsson; Thor Petersen; Pierre Grammond; Franco Granella; Vincent Van Pesch; Roberto Bergamaschi; Christopher McGuigan; Alasdair Coles; Jan Hillert; Fredrik Piehl; Helmut Butzkueven; Tomas Kalincik
Journal:  Lancet Neurol       Date:  2020-03-18       Impact factor: 44.182

Review 3.  Targeting progression in multiple sclerosis - an update.

Authors:  Maria A Rocca; Massimo Filippi
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

Review 4.  Diagnosis and Treatment of Multiple Sclerosis: A Review.

Authors:  Marisa P McGinley; Carolyn H Goldschmidt; Alexander D Rae-Grant
Journal:  JAMA       Date:  2021-02-23       Impact factor: 56.272

5.  Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.

Authors:  Lynn van Olst; Carla Rodriguez-Mogeda; Carmen Picon; Svenja Kiljan; Rachel E James; Alwin Kamermans; Susanne M A van der Pol; Lydian Knoop; Iliana Michailidou; Evelien Drost; Marc Franssen; Geert J Schenk; Jeroen J G Geurts; Sandra Amor; Nicholas D Mazarakis; Jack van Horssen; Helga E de Vries; Richard Reynolds; Maarten E Witte
Journal:  Acta Neuropathol       Date:  2021-03-29       Impact factor: 17.088

6.  Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.

Authors:  Anna Catharina van Loenhoud; Wiesje Maria van der Flier; Alle Meije Wink; Ellen Dicks; Colin Groot; Jos Twisk; Frederik Barkhof; Philip Scheltens; Rik Ossenkoppele
Journal:  Neurology       Date:  2019-07-02       Impact factor: 9.910

7.  Axon-Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter.

Authors:  Antonio Luchicchi; Bert't Hart; Irene Frigerio; Anne-Marie van Dam; Laura Perna; Herman L Offerhaus; Peter K Stys; Geert J Schenk; Jeroen J G Geurts
Journal:  Ann Neurol       Date:  2021-01-27       Impact factor: 10.422

8.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910

9.  Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.

Authors:  Xiaoming Jia; Lohith Madireddy; Stacy Caillier; Adam Santaniello; Federica Esposito; Giancarlo Comi; Olaf Stuve; Yuan Zhou; Bruce Taylor; Trevor Kilpatrick; Filippo Martinelli-Boneschi; Bruce A C Cree; Jorge R Oksenberg; Stephen L Hauser; Sergio E Baranzini
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.